Search for dissertations about: "Biomarkers and drugs"
Showing result 1 - 5 of 102 swedish dissertations containing the words Biomarkers and drugs.
-
1. The gastrointestinal tract in cardiac anaesthesia and intensive care : Clinical and experimental studies
Abstract : Gastrointestinal (GI) complications after cardiac surgery have a substantial impact on outcome. The aims were to investigate the frequency of, and methods for detecting, GI dysfunction after cardiac surgery and its relation to outcome, and the impact of vasoactive drugs on the GI tract in experimental cardiogenic shock. READ MORE
-
2. Different Aspects of Psoriasis : Comorbidity, Comedication and Disease Biomarkers
Abstract : Psoriasis is a common heterogeneous inflammatory disease with its predominant manifestation occurring in the skin. The impact of this disease, however, extends far beyond the skin surface. READ MORE
-
3. Depression in teenagers and young adults : foundational studies of the new treatment paradigm TARA: Training for Awareness, Resilience, and Action
Abstract : Introduction: Depression in adolescents and young adults is an increasing global health concern and available treatments are not convincingly effective. It is therefore important to develop and test novel treatments to improve treatment outcomes. READ MORE
-
4. Prognostic Biomarkers and Target Proteins for Treatment of High-grade Gliomas
Abstract : The survival for high-grade glioma patients is poor and the treatment may cause severe side effects. A common obstacle in the treatment is chemoresistance. To improve the quality of life and prolong survival for these patients prognostic biomarkers and new approaches for chemotherapy are needed. READ MORE
-
5. An integrative strategy for targeted evaluation of biomarker expression in non-small cell lung cancer
Abstract : Despite improvements in therapy, the prognosis for non-small cell lung cancer (NSCLC) patients remains poor, and cure is only possible in localized tumors after surgical resection. A new generation of targeted cancer drugs has led to the expectation that lung cancer therapy can be significantly improved, but these drugs are today only an option in a small subset of NSCLC patients, and their effect is temporary. READ MORE